BIO Asia–Taiwan 2025 亞洲生技大會

The exponential advancement of biotechnology in recent years has enabled its application in all industrial sectors, and under the name of the bioeconomy, while aiming to expand its market, it is increasingly being used as a means to solve numerous social issues. In line with this growing importance of the bioeconomy, the government of Japan has released the Bioeconomy Strategy in 2019, concentrating on the formation of networks and the promotion of open innovation based on the biocommunity as one of its focused points. In addition, pharmaceutical and other companies, which are aggressively seeking to enhance their own R&D activities through open innovation, are increasing their importance of alliances with other companies and networks for finding partners. In light of this circumstances, we have planned this session to introduce Japan's Bioeconomy Strategy and the activities of the two global biocommunities formed in accordance with this strategy, and to have two leading Japanese pharmaceutical companies speak about their open innovations. We hope that session will help you accelerate collaborations with Japanese organizations and companies.